How Do You Manage High Hematocrit on TRT? (TRT Q&As)
Timeline
The clinician describes men whose repeated blood donations have depleted ferritin and iron while hematocrit remains difficult to control. Dr. O’Connor discusses distinguishing androgen-induced erythrocytosis from polycythemia vera, evaluating cardiovascular and clotting risk, addressing sleep apnea and other contributors, adjusting androgen exposure, and using hematology consultation when appropriate.
The discussion emphasizes looking beyond testosterone and considering gastrointestinal blood loss, especially in men old enough for colorectal cancer screening. The clinicians stress appropriate GI evaluation rather than automatically assuming the low ferritin is simply related to TRT.
A clinician reports that several compounding pharmacies she works with have stopped supplying certain peptides. The group discusses increasing regulatory pressure surrounding compounded peptides and the importance of clinicians being cautious about prescribing products that may not be legally available.
The group discusses concerns about online clinics that prescribe testosterone and synthetic androgens without routinely seeing patients in person. Dr. O’Connor emphasizes practicing conservatively, documenting care carefully, and staying attentive to changing regulatory requirements.
The clinicians review a case in which SHBG dropped from the mid-30s to about 5 while testosterone dosing appeared unchanged. Further investigation showed the patient was also receiving Anavar, illustrating how undisclosed synthetic androgen use can substantially alter laboratory results.
Video Summary
The video features an Ask the Doc session focused on answering common questions from patients and affiliates. Topics discussed include how patients engage with services and what to expect from clinical interactions. The speaker addresses practical concerns rather than theoretical medicine. Emphasis is placed on clear communication and realistic expectations. Questions reflect issues patients commonly raise when navigating care. The session is framed as educational guidance, not individualized treatment advice.
Several questions focus on how clinical decisions are made and what information patients should provide. The video highlights the importance of accurate history, labs, and follow-up. Clarification is provided around timelines, evaluations, and common misunderstandings. The discussion reinforces that care decisions are individualized. Patients are encouraged to ask questions and stay engaged. Transparency in process is emphasized throughout.
The session also covers next steps after consultations and how ongoing communication is handled. Follow-up expectations and accountability are discussed. The video stresses that education supports better outcomes when paired with proper medical care. Limitations of virtual education versus direct care are acknowledged. Affiliates are reminded of appropriate messaging and scope. The key takeaway is informed participation within a structured care model.
Drug Callouts
Condition Callouts
Key Takeaways
- Ask the Doc sessions address common patient questions.
- Clear communication improves care experiences.
- Clinical decisions are individualized.
- Follow-up expectations matter.
- Education complements, not replaces, medical care.